“This year [a different vaccine] is completely unneeded. But by mid next year, it could be a different situation,” said Sahin in an interview with the Financial Times.
Ugur Sahin, CEO of BioNTech, sees a need for an updated Covid-19 vaccine by middle of next year as the virus further mutates.
BioNTech, together with Pfizer, developed what has been described as the first vaccine late last year.
